X

Xiamen Amoytop Biotech Co Ltd
SSE:688278

Watchlist Manager
Xiamen Amoytop Biotech Co Ltd
SSE:688278
Watchlist
Price: 71.69 CNY -3.54% Market Closed
Market Cap: 29.2B CNY
Have any thoughts about
Xiamen Amoytop Biotech Co Ltd?
Write Note

Relative Value

The Relative Value of one Xiamen Amoytop Biotech Co Ltd stock under the Base Case scenario is 107.92 CNY. Compared to the current market price of 71.69 CNY, Xiamen Amoytop Biotech Co Ltd is Undervalued by 34%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
107.92 CNY
Undervaluation 34%
Relative Value
Price
X
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
33
vs Industry
45
Median 3Y
10.3
Median 5Y
11.4
Industry
7.7
Forward
10.3
vs History
61
vs Industry
4
Median 3Y
50
Median 5Y
58.9
Industry
22.7
Forward
36.7
vs History
44
vs Industry
4
Median 3Y
46.7
Median 5Y
53
Industry
21.6
vs History
56
vs Industry
2
Median 3Y
132.5
Median 5Y
174.4
Industry
25.2
vs History
16
vs Industry
7
Median 3Y
11.3
Median 5Y
12.3
Industry
2.5
vs History
33
vs Industry
38
Median 3Y
10
Median 5Y
11.1
Industry
7.7
Forward
10
vs History
33
vs Industry
36
Median 3Y
11.1
Median 5Y
12
Industry
9
vs History
46
vs Industry
3
Median 3Y
37.7
Median 5Y
42.4
Industry
4.2
Forward
28
vs History
46
vs Industry
4
Median 3Y
37.7
Median 5Y
42.4
Industry
4.1
Forward
31.6
vs History
44
vs Industry
4
Median 3Y
45
Median 5Y
51.3
Industry
5.7
vs History
60
vs Industry
2
Median 3Y
122
Median 5Y
182.5
Industry
3.6
vs History
21
vs Industry
17
Median 3Y
13.1
Median 5Y
14.7
Industry
4.6

Multiples Across Competitors

Competitors Multiples
Xiamen Amoytop Biotech Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Xiamen Amoytop Biotech Co Ltd
SSE:688278
29.2B CNY 13.1 48.6 39.5 39.5
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 083 264.3 -181 004.1 -219 796.6 -217 288.5
US
Abbvie Inc
NYSE:ABBV
312.7B USD 5.6 61.5 15.3 23.6
US
Amgen Inc
NASDAQ:AMGN
158.3B USD 4.9 37.4 17.5 33.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.9B USD 10.9 -241.6 24 25.2
US
Gilead Sciences Inc
NASDAQ:GILD
112.4B USD 4 891.9 9.9 9.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 849.9 -472 -514.1 -500.3
AU
CSL Ltd
ASX:CSL
133.6B AUD 5.9 32.9 20.3 25.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD 5.9 17.8 16.2 18
US
Seagen Inc
F:SGT
39.3B EUR 17.8 -54.6 -58.7 -53
NL
argenx SE
XBRU:ARGX
34.5B EUR 18.5 -129.9 -104.5 -76.2
P/E Multiple
Earnings Growth
CN
X
Xiamen Amoytop Biotech Co Ltd
SSE:688278
Average P/E: 181.7
48.6
183%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -181 004.1 N/A
US
Abbvie Inc
NYSE:ABBV
61.5
412%
US
Amgen Inc
NASDAQ:AMGN
37.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -241.6
42%
US
Gilead Sciences Inc
NASDAQ:GILD
891.9
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -472 N/A
AU
CSL Ltd
ASX:CSL
32.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.6 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.9 N/A
EV/EBITDA Multiple
EBITDA Growth
CN
X
Xiamen Amoytop Biotech Co Ltd
SSE:688278
Average EV/EBITDA: 20.4
39.5
202%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 796.6 N/A
US
Abbvie Inc
NYSE:ABBV
15.3
29%
US
Amgen Inc
NASDAQ:AMGN
17.5
62%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
43%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
16%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514.1 N/A
AU
CSL Ltd
ASX:CSL
20.3
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
35%
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.5 N/A
EV/EBIT Multiple
EBIT Growth
CN
X
Xiamen Amoytop Biotech Co Ltd
SSE:688278
Average EV/EBIT: 24.9
39.5
143%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -217 288.5 N/A
US
Abbvie Inc
NYSE:ABBV
23.6
88%
US
Amgen Inc
NASDAQ:AMGN
33.1
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.2
44%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -500.3 N/A
AU
CSL Ltd
ASX:CSL
25.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.2 N/A

See Also

Discover More
Back to Top